Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices … -
G McKhann - Neurology, 1984 - AAN Enterprises
... Peptides in Cerebrospinal Fluid and Prediction of Progression of Mild ... in drug trials
accurately identify subjects with predementia Alzheimer's disease? ...

… and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 … -
PL McGeer - Neurology, 1996 - AAN Enterprises
... Protein, Interleukin 6, and Other Cardiovascular Biomarkers Arch Ophthalmol ... of Rofecoxib
or Naproxen vs Placebo on Alzheimer Disease Progression: A Randomized ...

MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease -
CR Jack Jr - Neurology, 1992 - AAN Enterprises
... Knopman, and RC Petersen MRI as a biomarker of disease progression in a ... and WJ JAGUST
Imaging Interactions between Alzheimer's Disease and Cerebrovascular ...

Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease -
CR Jack Jr - Neurology, 1997 - AAN Enterprises
... Cha, D. Knopman, and RC Petersen MRI as a biomarker of disease progression in a ... encoding
in young and elderly controls and mild Alzheimer's disease J. Neurol ...

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive … -
O Hansson, H Zetterberg, P Buchhave, E Londos, K … - Lancet Neurology, 2006 - Elsevier
... Here, we assess the association between CSF biomarkers and incipient Alzheimer's ...
The relative risk of progression to Alzheimer's disease was substantially ...

Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease -
CR Jack Jr - Neurology, 1998 - AAN Enterprises
... R. Cha, D. Knopman, and RC Petersen MRI as a biomarker of disease progression in
a ... Atrophy Correlates With Clinical Features of Alzheimer Disease in African ...

A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease. -
O Carrette, I Demalte, A Scherl, O Yalkinoglu, G … - Proteomics, 2003 - ncbi.nlm.nih.gov
... The diagnosis of Alzheimer's disease (AD), the most common form of dementia in ... and
perhaps the assessment of the severity and progression of the disease. ...

Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease -
E Masliah, M Mallory, M Alford, R DeTeresa, LA … - Neurology, 2001 - AAN Enterprises
... Hansen L, et al. Synaptic and neuritic alterations during the progression
of Alzheimer?s disease. Neurosci Lett 1994; 174 ...

Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease A 1H MRS study -
K Kantarci, CR Jack, YC Xu, NG Campeau, PC O'Brien … - Neurology, 2000 - AAN Enterprises
... may provide valuable information about the pathophysiologic progression of disease. ...
AG06786, AG16574, the DANA Foundation, and the Alzheimer?s Association ...

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease -
PV Arriagada - Neurology, 1992 - AAN Enterprises
... Home page, J Geriatr Psychiatry Neurol Home page M. Coats and JC Morris Antecedent
Biomarkers of Alzheimer's Disease: The Adult Children Study J Geriatr ...